Serial Number
87093137
Owner
Santhera Pharmaceuticals (Schweiz) AGAttorney
Maria A. ScungioFiling Date
Jul 5, 2016
OXITRAN Trademark
Serial Number: 87093137 • Registration: 5239739
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Hammerstrasse 47
4410 Liestal , CH
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
July 5, 2016
Registration Date
July 11, 2017
Published for Opposition
March 7, 2017
Cancellation Date
January 26, 2024
Goods & Services
Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of neuromuscular and ophthalmological diseases; Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; reagents for medical use in connection with the aforementioned diseases
Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating neuromuscular and ophthalmological diseases; reagents for scientific and medical research for use in the research of small molecule pharmaceuticals and research of the treatment of neuromuscular and ophthalmological diseases; all of the foregoing excluding cleaning agents for use in laboratories and industries
Medical research; scientific research; medical and scientific research, namely, conducting clinical trials for others; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; genetic animal model testing and scientific research for neuro-muscular and ophthalmological diseases for research purposes
